Skip to main content
Loading...
Menu social network
LinkedIn
Facebook
X
Youtube
Menu top
Assistance
User account menu
Log in
Main navigation
Home
Programme
Download the app
App
Download the app
App
Menu
Login
Close
Main navigation mobile
Home
Programme
Menu top
Assistance
Menu social network
LinkedIn
Facebook
X
Youtube
29 results
- D3.164 - Safety and Efficacy of VIT against Wasp Venom in Patients Older than 60 Years
- D3.165 - Consistent long term benefit of allergen immunotherapy in patients with allergic rhinitis
- D3.166 - The mental health of adolescent patients with cat allergy improves with rapid dosing of depigmented cat allergoids
- D3.167 - Allergoids: Characterising Identity Pre- and Post- Modification Using Compendial and Novel Methods
- D3.169 - Advantage of IgG reactivity testing for the analytical quantification of allergoids
- D3.172 - Аllergen-specific immunotherapy in patients with allergic rhinitis
- D3.173 - Nationwide pivotal registry study on house dust mite immunotherapy in allergic rhinitis patients with or without asthma in China (NAVIGATOR)
- D3.174 - Comparative analysis of extracts from Cupressus arizonica and Juniperus ashei pollens
- D3.175 - Tumor Necrosis Factor Receptor 2 (TNFR2) is crucial for the efficacy of Allergen-Specific Immunotherapy in a Pre-clinical Murine Model
- D3.176 - The value of TNF and IL1RN genes in predicting the clinical efficacy of SCIT in children with asthma
- D3.177 - Potency of Dermatophagoides spp SLIT tablet compared to US standardized mite in ID testing
D3.170 - Effectiveness and Safety Study of Subcutaneous Immunotherapy for Respiratory Allergy to Dermatophagoides and Lepidoglyphus Destructor
- D1.323 - Clinical Experience with Lanadelumab for Hereditary Angioedema in Kazakhstan
D3.317 - Moderate-to-severe infections and initial SELENA-SLEDAI correlate with the incidence of flares in patients with Systemic Lupus Erythematosus
D3.322 - Acquired chronic granulomatous disease secondary to myelodysplastic disorder
D3.324 - Mastoiditis as complication of Hyper IgM syndrome
D3.326 - A RARE COEXISTENCE: CARD9 DEFICIENCY AND IgG4-RELATED DISEASE IN A PEDIATRIC PATIENT
D3.327 - Use of C1 Inhibitor Subcutaneously in the United Kingdom
D3.328 - Relapsing COVID-19 pneumonia and Helicobacter cineadi cellulitis in a patient with X-linked agammaglobulinemia
D3.332 - Determination of Reference Intervals for IgG, IgA, and IgM Levels by Age in Healthy Adults
Pagination
Current page
1
Page
2
Next page
Next
Last page
Last
Download the app
The congress at your fingertips
Available on
Download